INSIDERFilingvia Quantisnow
Marker Therapeutics Inc. logo

Marker Therapeutics (MRKR) executive Hoang received 40,000 units

ByQuantisnow··Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Insider transactions reported

Tsvetelina P Hoang (executive at Marker Therapeutics Inc., MRKR) reported that they received 40,000 units on Feb 17, 2022.

Reporting person
Hoang Tsvetelina P

Options and other derivatives

Options and other derivative transactions
DateTypeSecuritySharesPriceValueHeld after
Feb 17, 2022Grant or award (A)Employee Stock Option (right to buy)On 40,000 Common Stock1+40,000--40,000 direct

Holdings before and after

  • Employee Stock Option (right to buy): 0 to 40,000 direct

Footnotes from the filing

  1. 1. This option vests in equal monthly installments over a four year period commencing on March 17, 2022 subject to the continued service by the Reporting Person to the Issuer as of the applicable vesting date.

Transaction codes in this filing

Grant or award:
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

FAQ

What did Hoang report in this MRKR Form 4?

Tsvetelina P Hoang (executive at Marker Therapeutics Inc., MRKR) reported that they received 40,000 units on Feb 17, 2022.

What does transaction code A mean on an SEC Form 4?

Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

Historical context for MRKR

Earlier insider filings at MRKR

Quantisnow market dataNASDAQ
Marker Therapeutics Inc. logo
MRKR
Marker Therapeutics Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Get push alerts for MRKR

Follow MRKR and get a push notification the moment its next story breaks.

Full MRKR profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MRKR (Marker Therapeutics Inc.) and more on Quantisnow.